MENU
Anika Therapeutics (ANIK) Ownership - Who owns Anika Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
32 Wiggins Avenue
Phone
+1 781 457-9000
Employees
357
Web
https://www.anika.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
381.94M
P/E Ratio
72.99
Total Cash
72.87M
Projected Growth
2.30
Total Debt
29.04M
Revenue
166.66M
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash/Share
4.91
Total Debt/Equity
N/A
Revenue/Share
11.37 USD as % of share price
Fundamentals
ANIK
Capitalization
382M
P/E Ratio
72.99
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash
72.9M
Total Cash/Share
4.91
Total Debt
29M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
2.30
Revenue/Share (as % of the share price)
11.37%
Revenue
167M
ROE
N/A
Book Value
212M
P/B Ratio
1.80
Cash Flow
N/A
Earnings
-5.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
147K
Current Ratio
5.26
Current Revenue Per Employee
120366.95
Dividends Per Share - Security
N/A
EBITDA
-11.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
61.27
Revenue To Assets
-26.68
Shares Held By Institutions
412M
Shares Outstanding - Current
14.8M
Total Liabilities
58.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
12.136
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts